Gilead Sciences, Inc. - Feb 18, 2025 SCHEDULE 13D/A Report for Arcus Biosciences, Inc. Common Stock, par value $0.0001 (RCUS)

Filing Manager: GILEAD SCIENCES, INC.
Reporting Manager: GILEAD SCIENCES, INC.
Security: Arcus Biosciences, Inc. Common Stock, par value $0.0001
Symbol: RCUS
Shares outstanding: 113M shares
Disclosed Ownership: 39.7M shares
Ownership: 35%
Form type: SCHEDULE 13D/A
Date filed: 2/20/2025, 07:43 PM
Date of event: Feb 18, 2025
Next filing: Jul 15, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GILEAD SCIENCES, INC.	35%	39.7M	39.7M	0	/s/ Andrew D. Dickinson	Andrew D. Dickinson, Executive Vice President and Chief Financial Officer	0000882095